Find therapies in clinical trials near you – page 787

Study on the Effectiveness and Safety of Lamivudine, Dolutegravir Sodium, Cabotegravir, and Rilpivirine for Adults with HIV-1 Who Have Not Taken Antiretroviral Therapy

Study on the Effectiveness and Safety of Lamivudine, Dolutegravir Sodium, Cabotegravir, and Rilpivirine for Adults with HIV-1 Who Have Not Taken Antiretroviral Therapy

Study on Pyridoxine for Patients with Primary Sclerosing Cholangitis

Study on Pyridoxine for Patients with Primary Sclerosing Cholangitis

Study on the Effects of Semaglutide on Inflammation in Patients with Alzheimer's Disease

Study on the Effects of Semaglutide on Inflammation in Patients with Alzheimer's Disease

Study Comparing Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Patients with Untreated Multiple Myeloma Not Planning Stem Cell Transplant

Study Comparing Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Patients with Untreated Multiple Myeloma Not Planning Stem Cell Transplant

Study on the Effectiveness and Safety of Tirbanibulin Ointment for Adults with Actinic Keratosis on the Face or Scalp

Study on the Effectiveness and Safety of Tirbanibulin Ointment for Adults with Actinic Keratosis on the Face or Scalp

Study of Ibrutinib and Rituximab for Patients with Relapsed or Refractory Mantle Cell Lymphoma

Study of Ibrutinib and Rituximab for Patients with Relapsed or Refractory Mantle Cell Lymphoma

Study of Pembrolizumab with Chemotherapy for Children and Young Adults with Classical Hodgkin Lymphoma Not Responding Well to Initial Treatment

Study of Pembrolizumab with Chemotherapy for Children and Young Adults with Classical Hodgkin Lymphoma Not Responding Well to Initial Treatment

Study on the Effectiveness and Safety of Follitropin Delta for Men with Unexplained Infertility

Study on the Effectiveness and Safety of Follitropin Delta for Men with Unexplained Infertility

Study of Ravulizumab for Children with Thrombotic Microangiopathy After Stem Cell Transplant

Study on Galcanezumab for Preventing Episodic Migraine in Children and Teens Aged 6 to 17

Study on Galcanezumab for Preventing Episodic Migraine in Children and Teens Aged 6 to 17

Study on Galcanezumab for Preventing Chronic Migraine in Adolescents Aged 12 to 17

Study on Galcanezumab for Preventing Chronic Migraine in Adolescents Aged 12 to 17

Study on the Safety of Tenofovir Alafenamide and Natalizumab for People with Multiple Sclerosis

Study on the Safety of Tenofovir Alafenamide and Natalizumab for People with Multiple Sclerosis